Clinical Trial Update: Albumin Modifications as Early Biomarkers of Chronic Liver Diseases [NA]

View source ↗

Summary

A clinical trial investigating albumin modifications as early biomarkers for chronic liver disease; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Snippet

Sponsor: University Hospital, Limoges | Conditions: Chronic Liver Disease | NA | Status: RECRUITING